The Harvard scientist has unveiled a major breakthrough in the anti-aging process.
At the Dubai Summit 2026, Dr David Sinclair explained that aging is a treatable medical condition and not inevitable. He predicts that biotechnology will make modern healthcare obsolete within ten to twenty years, shifting from symptom management to a complete reversal of biological aging.
According to Sinclair, his team’s partial epigenetic reprogramming has managed to reverse aging markers in animal studies by 75 percent using modified Yamanaka genes and has restored vision in animals suffering from blindness models.
Sinclair confirmed: “Scientists have found ways to ‘polish’ the biological system and restore cellular function.”
Now the team is preparing for human clinical trials to reverse aspects of aging. The trials will test epigenetic programming therapies designed to restore cells to a younger state.
“We are about to test for the first time in history whether we can reverse aging and cure disease,” he said.
Sinclair also sheds light on how breakthroughs in anti-aging can also bring economic benefits.
In the US, extending healthy lifespans by just one year could save an estimated $38 trillion by improving productivity.
He also linked his anti-aging research to poor fertility rates and declining birth rates, arguing that societies may face the dilemma of replacing workers with robots or keeping them healthy longer.
“Our greatest asset is human productivity,” Sinclair said.
Trials are expected to begin soon, but exact details have not yet been announced.
